Immunity to Chalmydia trachomatis: lessons from a Gambian village

References

1. Dawson C. R., Jones B. R., Tarizzo M. L. A guide to trachoma control. In Programmes for the prevention of blindness Geneva: World Health Organization; 1981
   [Google Scholar]
2. Schachter J., Dawson C. R. Human chlamydial infections. Littleton M. A.: P. S. G. Publishing Co; 1978
   [Google Scholar]
3. Piot P., Van den Hoek J. A. R., Van Damme L., Laga M. Epidemiology and control of chlamydial infection. In Orfila J., Byrne G. I., Chemesky M. A. (eds) Chlamydial infections Bologna: Societa Editrice Esculapio; 19947–16
   [Google Scholar]
4. Mabey D. C. W., Robertson J. N., Ward M. E. Detection of Chlamydia trachomatis by enzyme immunoassay in patients with trachoma. Lancet 1987; 2:1491–1492
   [Google Scholar]
5. Woolridge R. L., Grayston J. T., Chang I. H., Cheng K. H., Yang C. Y., Neave C. Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol 1967; 63:1645–1650
   [Google Scholar]
6. Wang S.-P., Grayston J. T., Alexander E. R. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967; 63:1615–1630
   [Google Scholar]
7. Morrison R. P., Lyng K., Caldwell H. D. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57 kDa protein. J Exp Med 1989; 169:663–675
   [Google Scholar]
8. Bailey R., Osmond C., Mabey D. C. W., Whittle H. C., Ward M. E. Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. Int J Epidemiol 1989; 18:944–951
   [Google Scholar]
9. Bailey R. L., Kajbaf M., Whittle H. C., Ward M. E., Mabey D. C. W. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect 1993; 111:315–324
   [Google Scholar]
10. Peeling R. W., Maclean I. W., Branham R. C. In vitro neutralization of Chlamydia trachomatis with monoclonal antobodies to an epitope on the major outer membrane protein. Infect Immun 1984; 46:484–488
    [Google Scholar]
11. Hayes L. J., Pecharatana S., Bailey R. L. Extent and kinetics of genetic change in the ompI gene of Chlamydia trachomatis in two villages with endemic trachoma. J Infect Dis 1995; 172:268–272
    [Google Scholar]
12. Holland M. J., Bailey R. L., Hayes L. J., Whittle H. C., Mabey D. C. W. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J Infect Dis 1993; 168:1528–1531
    [Google Scholar]
13. Bailey R. L., Holland M. J., Whittle H. C., Mabey D. C. W. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 1995; 63:389–392
    [Google Scholar]
14. Byrne G. I., Grubbs B., Marshall T. J., Schachter J., Williams D. M. Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun 1988; 56:2023–2027
    [Google Scholar]
15. Byrne G. I., Grubbs B., Dickey T. J., Schachter J., Williams D. M. Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis 1987; 156:993–996
    [Google Scholar]
16. Sadick M. D., Heinzel F. P., Holaday B. J., Pu R. T., Dawkins R. S., Locksley R. M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990; 171:115–127
    [Google Scholar]
17. Yamamura M., Uyemura K., Deans R. J. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277–279
    [Google Scholar]